NFKB1 and Miyoshi myopathy: For this, in MM, the malignant plasma cells (PCs) and the cells of the bone marrow (BM) act in a distinctive interplay, including a complex cytokine signaling, which activates downstream pathways, one being the NF‐κB pathway [27].